Scientific deep-dive

Red Light Therapy for Weight Loss: Cleared for Inches, Never for Pounds

FDA has never cleared red light or low-level laser therapy for weight loss. Its clearances cover a small aesthetic cut in waist, hip, thigh or arm circumference. What the sham-controlled trials measured, who paid for them, and how fast the inches return.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
10 min read·27 citations

Part of Weight-loss gadgets and wellness trends

Red light therapy does not cause meaningful weight loss. What it can do, in trials paid for or co-authored by device makers, is shave a few centimeters off a tape measure at the spot being treated, and some of that comes back within weeks. FDA has never cleared a red light or low-level laser device for weight loss. The devices in its “fat reducing low level laser” category are cleared for an aesthetic “reduction of circumference” of the hips, waist, thighs, abdomen or arms.[3][5] In a sham-controlled trial on the upper arms, body mass index did not change.[11]

About this article. Device claims come from FDA’s own 510(k) database and the clearance letters and summaries it publishes. Study results come from the published trials and reviews, with funding noted where the papers disclose it. The terms “red light therapy,” “low-level laser therapy” (LLLT) and “photobiomodulation” describe the same idea: low-power red or near-infrared light that does not heat or burn tissue. This is not medical advice.

What FDA cleared, in its own words

FDA created a device type for this in 2011: a “low level laser system for aesthetic use,” defined as a device that uses low-level laser energy “for the disruption of adipocyte cells within the fat layer for the release of fat and lipids from these cells for noninvasive aesthetic use.” It is a Class II device under special controls.[1] Its product code is OLI, “Fat Reducing Low Level Laser.”[3]

Almost every device under that code reached the market through a 510(k), which means FDA found it “substantially equivalent” to a device already on the market.[2] A 510(k) clearance is not an approval that the device works for the buyer’s goal. It is a finding that the device matches an earlier one for a stated use. As of FDA’s October 2026 data, the OLI code held 33 records, from the first in August 2010 to an LED belt cleared in May 2026. Sixteen belong to Erchonia, the maker of the Zerona lasers.[3] The later ones include LED panels, wraps and full-body beds, which is what most “red light” spas use.

“The Zerona® Z6 OTC device is indicated for use as a non-invasive dermatological aesthetic treatment for the reduction of circumference of hips, waist, and thighs.”[5]
— FDA 510(k) K143007, Zerona Z6 OTC, indications for use
What a sample of FDA clearances for fat-reducing light devices permit, paraphrased from FDA’s documents
Device and clearanceCleared use, in briefNew clinical data submitted?
Zerona, K121695 (2012)[4]Smaller hips, waist and thighs, as an add-on for people already planning liposuctionNot stated in the summary
Erchonia SHL, K142042 (2014)[27]Smaller hips, waist and upper abdomen, in adults with a BMI of 30 to 40Not stated in the summary
Zerona Z6 OTC, K143007 (2015)[5]Smaller hips, waist and thighs; no liposuction plan requiredNot stated in the summary
Zerona Z-Bed, K220519 (2022)[6]Smaller body measurements generally; sold over the counterNo new clinical study
Zerona VZ8, K243811 (2025)[7]Smaller body measurements generally; sold over the counterNo new clinical study
LED phototherapy bed, K252786 (2025)[8]Smaller hips, waist and thighs; also gentle heat for minor achesBench testing only
LED panel, K260129 (2026)[9]Smaller hips, waist and thighs; also wrinkles and heatFDA summary says clinical testing was not needed

None of the cleared uses in FDA’s published clearance documents for this code is weight loss. Where body mass index appears, it defines who may be treated, as in the clearance for people with a BMI of 30 to 40, and the promised result is still a smaller tape measurement.[27] The first Zerona clearance was for people who were already planning liposuction. And many newer devices, including LED beds and panels sold for home or spa use, were cleared by comparison to older ones with no new clinical study at all.[6][8][9] When a spa says its bed is “FDA cleared for fat loss,” the record says something narrower: cleared for a tape-measure change, on the strength of an older device’s data.

The sham-controlled trials: what they measured

The trials behind these devices measured circumference with a tape, usually summed across several sites. Summing four or five measurements makes a small change at each site look larger. The core randomized trials with a fake-light comparison group:

Randomized, sham-controlled trials of low-level laser body contouring
TrialWho and how longLight groupSham groupFunding or ties disclosed
Jackson 2009[10]67 adults, BMI 25–30; 6 sessions over 2 weeks−3.51 in summed over waist, hips and both thighs−0.68 inNot stated in the abstract
Caruso-Davis 2011[12]40 adults, BMI under 30; 8 waist sessions over 4 weeks−0.78 cm waist+1.35 cm waistGrant from Meridian Medical, the device maker
Nestor 2012[11]40 adults; 6 upper-arm sessions over 2 weeks−3.7 cm summed over 3 points per arm−0.2 cmGrant from Erchonia; lead author paid speaker for Erchonia
Roche 2017[13]53 adults, BMI 30–40; 12 sessions over 4 weeks−10.5 cm summed over hip, waist and upper abdomen−1.8 cmCo-author from Erchonia

Put per site, the effects are small. In the 2009 trial the waist fell by just under an inch and each thigh by less than one.[10] In the 2011 trial, the gap between groups was about 2 centimeters at the waist, and part of that gap came from the sham group’s waists getting bigger. That trial also counted only people whose weight stayed within 1.5 kg during the study, so it says nothing about weight by design.[12] In the arm trial, body mass index “remained unchanged for all subjects.”[11]

A 2025 systematic review found only three randomized trials that met its standards for tape-measured circumference, with 160 people between them. Laser groups lost 2.48 cm at the waist against 0.64 cm in controls. The reviewers wrote that varying protocols and follow-up times made it hard to judge “long-term efficacy.”[19]

The bigger numbers come from studies without a control group

Larger inch-loss figures in marketing tend to trace to studies with no comparison group. A six-week, once-a-week study of 54 people reported 5.4 inches summed over four sites, with no sham arm.[14] A single clinic’s retrospective review of 86 patients reported about 3 inches.[15] A pooled set of 689 clinic reports found 3.27 inches at the treated sites and smaller measurements at untreated sites too, including the neck and knees.[16] The authors read that as a whole-body effect. It is also what you would expect if measurement technique, timing or water balance shifted between visits, and without a control group there is no way to tell which.

Does the fat layer actually get thinner?

Tape measures cannot tell fat from fluid. The studies that looked under the skin are less encouraging. In a split-body study of the Zerona laser, one side treated and the other not, there was no significant change in circumference or in fat thickness on ultrasound, and blinded dermatologists picked the “after” photos correctly 51% of the time, no better than a coin toss. Every participant said the effect was less than expected.[17] It had five people, so it proves little alone.

A larger university-funded study in Poland treated one side of the abdomen and left the other side alone, measuring both by ultrasound. It could not show a significant reduction in fat thickness. In 8 of 17 people, the treated side came out relatively thicker. Two people had severe skin injuries, one an ulcer inside an old appendectomy scar, from a device with panels resting directly on the skin.[18]

The proposed mechanism has never been settled. A widely cited 2013 review described the leading idea, light opening temporary pores in fat cells so lipids leak out, and concluded that evidence for LLLT “as a stand-alone procedure” was still inadequate.[23] Lab work in one of the device trials found fat cells released triglyceride without breaking down.[12] If fat does leak out of cells, the body has to burn it somewhere. Nothing in the record shows that it does so in a way that shows up on a scale.

What happens to weight and metabolic markers

The trials designed to measure weight found very little. A Mayo Clinic pilot randomized 60 overweight adults to three laser schedules with no sham group. The best schedule produced about 1 kg of weight loss by week six.[21] An earlier Mayo pilot compared laser treatments with the weight-loss drug lorcaserin. On laser alone, weight fell 0.4 kg over three months, which was not significant. On the drug, it fell 1.3 kg.[22]

The most favorable number comes from a 2025 meta-analysis of 11 trials in people with obesity, which pooled a 3.5 kg greater weight loss with light treatment. The detail is weaker than that headline. The authors rated the weight result low-certainty evidence. Most trials added light to a diet or exercise program in Brazil or Egypt, none ran longer than six months, and the change in body-fat percentage was not significant.[20] The authors themselves wrote that against diet, exercise and sham controls, light therapy “did not demonstrate consistent advantages in reducing weight and BMI.”[20] A typical trial in that set gave women 16 weeks of supervised training three times a week, with or without laser after each session.[25] That is a long way from lying under a panel at home.

For cholesterol and other blood fats, a 2022 review of 15 studies concluded that light used for local fat reduction does not change serum lipid levels when used on its own.[24] If fat were leaving cells in quantity, those are the numbers you would expect to move.

How long do the results last?

Not long, as far as the trials show. In the 2009 trial, the laser group had regained 0.31 inches in total two weeks after the last session.[10] The current Zerona protocol is six sessions in two weeks,[7] and most trials stopped measuring two weeks later. The Mayo pilot, one of the few with longer follow-up, found its best group’s waist reduction shrank from 2.0 inches at week six to 1.5 inches at week 26, without a sham group to compare against.[21] No trial has followed people for a year.

Red light therapy and GLP-1 drugs

No study has tested red light or low-level laser therapy alongside semaglutide, tirzepatide or any other GLP-1 drug. A search of ClinicalTrials.gov in October 2026 found 19 registered studies of light or laser treatments in obesity, and none that pairs them with a GLP-1 medicine.[26] There is no evidence that light speeds up GLP-1 weight loss, targets belly fat on the drug, or prevents loose skin after it. Loose skin after large weight loss is a skin problem, not a fat problem, and our guide to when skin removal surgery is safe covers what does remove it.

The best sham-controlled laser trial in people with obesity reported its result in centimeters: about 9 cm of summed circumference difference over three sites after a month.[13] GLP-1 drug trials measure weight in pounds lost over many months; see the semaglutide results timeline and the tirzepatide results timeline. GLP-1 trials measure body composition across the whole body, not by region, as our page on “Ozempic butt” explains, and the fat-to-lean mix is what they track. No device has been shown to steer where that fat comes off.

Is it safe?

Most trials reported no adverse events, which fits low-power light that does not heat tissue.[11][13] The exception is the Polish study, where panels placed directly on the skin caused two severe skin injuries in 17 people.[18] The more common harm is to the wallet. Cleared protocols call for repeated sessions, results fade, and the claims made in spas often go well past what the clearance says. The same gap between label and pitch runs through HCG and lipotropic shots and GLP-1 supplements.

If the goal is a visible change in one area without surgery, fat freezing has its own trial record, touched on in our page on GLP-1s and penis size. If the goal is weight, red light therapy is not a weight-loss treatment, and FDA has never said it is.

Frequently Asked Questions

No meaningful amount. Trials that measured weight found about 1 kg or less from light alone, often not significantly different from nothing. The sham-controlled body-contouring trial that reported body mass index found it unchanged. The devices are cleared to reduce circumference, not weight.
No device is approved or cleared for weight loss. FDA lists 33 clearances under its fat-reducing laser code, mostly low-level lasers and LED panels, beds and belts. Their published uses are aesthetic: a reduction of circumference of areas such as the hips, waist, thighs or arms. Several newer LED beds and panels were cleared without any new clinical study.
In sham-controlled trials, the difference from fake treatment was roughly 2 to 9 cm summed across several measuring points, which works out to about an inch or less at any single spot. Part of it returned within two weeks of stopping in the trial that checked.
There is little evidence they do. One trial found the laser group regaining 0.31 inches within two weeks of the last session, and no trial has followed people for a year.
No study has tested the combination, so there is no evidence it adds weight loss, targets fat in a particular area, or prevents loose skin. Low-power light is generally low risk, but it is not a substitute for the drug or for skin surgery.

References

  1. 1.Code of Federal Regulations 21 CFR 878.5400, Low level laser system for aesthetic use eCFR. 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-878/subpart-F/section-878.5400
  2. 2.U.S. Food and Drug Administration Premarket Notification 510(k) FDA. 2026. https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k
  3. 3.U.S. Food and Drug Administration 510(k) Premarket Notification database, product code OLI (Fat Reducing Low Level Laser) FDA. 2026. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?start_search=1&productcode=OLI&PAGENUM=50
  4. 4.U.S. Food and Drug Administration 510(k) K121695, Erchonia Zerona: clearance letter and indications for use FDA. 2012. https://www.accessdata.fda.gov/cdrh_docs/pdf12/K121695.pdf
  5. 5.U.S. Food and Drug Administration 510(k) K143007, Erchonia Zerona Z6 OTC: clearance letter and indications for use FDA. 2015. https://www.accessdata.fda.gov/cdrh_docs/pdf14/K143007.pdf
  6. 6.U.S. Food and Drug Administration 510(k) K220519, Erchonia Zerona Z-Bed: clearance letter and 510(k) summary FDA. 2022. https://www.accessdata.fda.gov/cdrh_docs/pdf22/K220519.pdf
  7. 7.U.S. Food and Drug Administration 510(k) K243811, Erchonia Zerona VZ8: clearance letter and 510(k) summary FDA. 2025. https://www.accessdata.fda.gov/cdrh_docs/pdf24/K243811.pdf
  8. 8.U.S. Food and Drug Administration 510(k) K252786, LED Light Phototherapy Bed: clearance letter and 510(k) summary FDA. 2025. https://www.accessdata.fda.gov/cdrh_docs/pdf25/K252786.pdf
  9. 9.U.S. Food and Drug Administration 510(k) K260129, Lumaflex Panel: clearance letter and 510(k) summary FDA. 2026. https://www.accessdata.fda.gov/cdrh_docs/pdf26/K260129.pdf
  10. 10.Jackson RF, Dedo DD, Roche GC, et al. Low-level laser therapy as a non-invasive approach for body contouring: a randomized, controlled study Lasers Surg Med. 2009. PMID: 20014253.
  11. 11.Nestor MS, Zarraga MB, Park H Effect of 635nm low-level laser therapy on upper arm circumference reduction: a double-blind, randomized, sham-controlled trial J Clin Aesthet Dermatol. 2012. PMID: 22468172.
  12. 12.Caruso-Davis MK, Guillot TS, Podichetty VK, et al. Efficacy of low-level laser therapy for body contouring and spot fat reduction Obes Surg. 2011. PMID: 20393809.
  13. 13.Roche GC, Shanks S, Jackson RF, et al. Low-level laser therapy for reducing the hip, waist, and upper abdomen circumference of individuals with obesity Photomed Laser Surg. 2017. PMID: 27935737.
  14. 14.Thornfeldt CR, Thaxton PM, Hornfeldt CS A six-week low-level laser therapy protocol is effective for reducing waist, hip, thigh, and upper abdomen circumference J Clin Aesthet Dermatol. 2016. PMID: 27386049.
  15. 15.McRae E, Boris J Independent evaluation of low-level laser therapy at 635 nm for non-invasive body contouring of the waist, hips, and thighs Lasers Surg Med. 2013. PMID: 23355338.
  16. 16.Jackson RF, Stern FA, Neira R, et al. Application of low-level laser therapy for noninvasive body contouring Lasers Surg Med. 2012. PMID: 22362380.
  17. 17.Elm CM, Wallander ID, Endrizzi B, et al. Efficacy of a multiple diode laser system for body contouring Lasers Surg Med. 2011. PMID: 21384392.
  18. 18.Jankowski M, Gawrych M, Adamska U, et al. Low-level laser therapy (LLLT) does not reduce subcutaneous adipose tissue by local adipocyte injury but rather by modulation of systemic lipid metabolism Lasers Med Sci. 2017. PMID: 27384041.
  19. 19.Mustafa GA, Alawi YF, Kasem MS, et al. Low-level laser therapy for reducing body circumferences: a systematic review Lasers Med Sci. 2025. PMID: 41423522.
  20. 20.Sun W, Zhuang Z, Yang L, et al. Effectiveness of photobiomodulation therapy in improving health indicators in obese patients: a systematic review and meta-analysis of RCTs BMC Complement Med Ther. 2025. PMID: 40217252.
  21. 21.Croghan IT, Hurt RT, Schroeder DR, et al. Low-level laser therapy for weight reduction: a randomized pilot study Lasers Med Sci. 2020. PMID: 31473867.
  22. 22.Croghan IT, Ebbert JO, Schroeder DR, et al. A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss BMC Obes. 2016. PMID: 27708788.
  23. 23.Avci P, Nyame TT, Gupta GK, et al. Low-level laser therapy for fat layer reduction: a comprehensive review Lasers Surg Med. 2013. PMID: 23749426.
  24. 24.Sena MM, Marreira M, de Almeida GP, et al. Can the use of photobiomodulation for localized fat reduction induce changes in lipid profile? A critical integrative review Lasers Med Sci. 2022. PMID: 36564660.
  25. 25.Duarte FO, Sene-Fiorese M, de Aquino Junior AE, et al. Can low-level laser therapy (LLLT) associated with an aerobic plus resistance training change the cardiometabolic risk in obese women? A placebo-controlled clinical trial J Photochem Photobiol B. 2015. PMID: 26398817.
  26. 26.ClinicalTrials.gov Search: obesity studies with photobiomodulation, low-level laser or red light interventions U.S. National Library of Medicine. 2026. https://clinicaltrials.gov/search?cond=obesity&intr=photobiomodulation
  27. 27.U.S. Food and Drug Administration 510(k) K142042, Erchonia SHL: clearance letter and indications for use FDA. 2014. https://www.accessdata.fda.gov/cdrh_docs/pdf14/K142042.pdf

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.6

Strut Health

Semaglutide at $99/month, well below the typical price

7.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

9.0

YourEra

Semaglutide at $99/month, well below the typical price

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →